FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

703673007: Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520826018 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559322015 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3009237018 SGLT2 inhibitor - Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3009365018 Sodium glucose cotransporter subtype 2 inhibitor en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3009684010 Sodium glucose cotransporter subtype 2 inhibitor (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
3009684010 Sodium glucose cotransporter subtype 2 inhibitor (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3520826018 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3559322015 Substance with sodium glucose cotransporter subtype 2 inhibitor mechanism of action en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

11 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sodium glucose cotransporter subtype 2 inhibitor Is a agent antidiabétique false Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor Is a Enzyme inhibitor false Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor Is a Drug or medicament (substance) false Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor Has disposition Sodium glucose cotransporter subtype 2 inhibitor (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor Is a Substance categorized by disposition false Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor Is a Substance with cellular transport inhibitor mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Inbound Relationships Type Active Source Characteristic Refinability Group
Dapagliflozin (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Canagliflozin (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Empagliflozin Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Sodium glucose cotransporter subtype 2 inhibitor-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept) 1
Ertugliflozin Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Canagliflozin hemihydrate (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol monohydrate (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Ertugliflozin pidolate (substance) Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Remogliflozin etabonate Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Canagliflozin anhydrous Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)
Dapagliflozin propanediol anhydrous Is a True Sodium glucose cotransporter subtype 2 inhibitor Inferred relationship Existential restriction modifier (core metadata concept)

This concept is not in any reference sets

Back to Start